CliffBio
small molecule

MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyXIAMEN LP PHARMACUETICAL CO LTD

Drug detail

Brand nameMEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
Active ingredientDONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
Strength10MG;28MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2025
Marketing statusRX

More from XIAMEN LP PHARMACUETICAL CO LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio